Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice.

CompletedOBSERVATIONAL
Enrollment

980

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
AsthmaQuality of Life
Interventions
OTHER

Budesonide/Formoterol treated patients

patients who are eligible to start their treatment with budesonide/formoterol therapy

Trial Locations (1)

Athens 11527

7th Pulmonary Dept, Athens Chest Hospital, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY